Quantum Biopharma Statistics
NASDAQ: QNTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.11-0.035 (-1.11%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Quantum Biopharma by the numbers
Quantum Biopharma has a market capitalization of $20.0 million based on 6.43M shares outstanding. With trailing EPS of $-4.98, Quantum Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.6% below its 50-day average and 28.2% below its 200-day average.
Average daily trading volume is 205.09K shares, or about $637,814 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
QNTM valuation vs. peer median
| Metric | QNTM | Peer median | Difference |
|---|---|---|---|
| Market cap | $20.00M | $20.81M | -4% |
| Avg. volume | 205.09K | 58.09K | +253% |
Peer median across 8 companies: COCP, UPC, QNRX, AKTX, AYTU, NEUP, NCEL, TXMD.
Valuation
- Market cap
- $20.00M
- EPS (TTM)
- $-4.98
- Shares outstanding
- 6.43M
Price and trading
- Previous close
- 3.15
- Open
- 3.10
- Day range
- 3.10 – 3.23
- 52-week range
- 2.07 – 16.36
- 52-week change
- -81.69%
- Beta
- —
- Volume
- 77.25K
- Average volume
- 205.09K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 20.00M
- Forward Pe
- -0.40
- Eps
- -4.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.36
- Week52 Low
- 2.07
- Avg Volume
- 205.09K
- Shares Outstanding
- 6.43M
- Ma50
- 3.37
- Ma200
- 4.33
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -80.99%
- Pct From52w Low
- 50.24%